Sudarshan Pharma Industries Current Share Price | Sudarshan Pharma Industries Stock Screener
SUDARSHAN
Dyes & Pigments
Sudarshan Pharma Industries Current Stock Price Today
Track the current Sudarshan Pharma Industries share price and stock price live with TickJournal's free stock screener.
Browse SUDARSHAN balance sheet details to support your investment research.
Use the Sudarshan Pharma Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sudarshan Pharma Industries Market Cap
₹973.67 Cr.
SUDARSHAN P/E Ratio (TTM)
39.45
Sudarshan Pharma Industries P/B Ratio
5.79
EPS (TTM)
₹0.97
Dividend Yield
-
Debt to Equity
1.13
SUDARSHAN 52 Week High
-
Sudarshan Pharma Industries 52 Week Low
-
Operating Margin
9.00%
Profit Margin
3.41%
SUDARSHAN Revenue (TTM)
₹176.00
EBITDA
₹17.00
Net Income
₹6.00
Total Assets
₹642.00
Total Equity
₹155.00
Sudarshan Pharma Industries Current Share Price Chart
Track the current Sudarshan Pharma Industries share price and stock price with an interactive chart. Analyse SUDARSHAN price trends, trading volume, historical performance, and volatility across different timeframes — the complete Sudarshan Pharma Industries stock quote in one place.
Sudarshan Pharma Industries Company Profile - Fundamental Screener
Screen Sudarshan Pharma Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SUDARSHAN shares.
Sector
Chemicals
Industry
Dyes & Pigments
Sub-Sector
Dyes & Pigments
Segment
E
ISIN
INE00TV01023
Sudarshan Pharma Industries Balance Sheet Screener
Screen SUDARSHAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 642 | 402 | 283 | 233 | 138 | 99 | 58 |
| Current Assets | 490 | 335 | 242 | 199 | 130 | 88 | 47 |
| Fixed Assets | 102 | 24 | 26 | 20 | 7 | 6 | 6 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 29 | 11 | 11 | 13 | 5 | 6 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 155 | 132 | 112 | 101 | 30 | 23 | 20 |
| Share Capital | 24 | 24 | 24 | 24 | 10 | 10 | 10 |
| Reserves & Surplus | 131 | 104 | 88 | 77 | 20 | 13 | 10 |
Sudarshan Pharma Industries Income Statement Screener - Profit & Revenue Analysis
Screen Sudarshan Pharma Industries income statement and profit fundamentals.
Analyze SUDARSHAN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sudarshan Pharma Industries share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 176 | 225 | 170 | 171 | 147 | 162 | 116 | 129 | 100 | 232 |
| Expenses | 159 | 201 | 157 | 160 | 134 | 147 | 108 | 117 | 97 | 217 |
| EBITDA | 17 | 24 | 12 | 11 | 12 | 15 | 9 | 12 | 3 | 15 |
| Operating Profit % | 9.00% | 9.00% | 6.00% | 5.00% | 8.00% | 9.00% | 7.00% | 9.00% | 2.00% | 6.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 8 | 8 | 6 | 6 | 6 | 4 | 4 | 4 | 4 | 6 |
| Profit Before Tax | 8 | 16 | 5 | 4 | 5 | 10 | 4 | 8 | -2 | 9 |
| Tax | 2 | 4 | 1 | 0 | 1 | 3 | 1 | 2 | 0 | 2 |
| Net Profit | 6 | 11 | 4 | 4 | 4 | 7 | 3 | 6 | -1 | 7 |
| EPS | 0.23 | 0.48 | 0.18 | 0.16 | 0.16 | 0.29 | 0.12 | 0.24 | -0.05 | 0.27 |
Sudarshan Pharma Industries Cash Flow Screener - Liquidity Fundamentals
Screen SUDARSHAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 35 | 6 | -29 | -4 | 3 | 1 |
| Investing Activities | -20 | -6 | -26 | -2 | -1 | -3 |
| Financing Activities | -14 | -12 | 66 | 4 | -2 | 0 |
| Net Cash Flow | 0 | -12 | 12 | -1 | 0 | -2 |
Sudarshan Pharma Industries Shareholding Pattern Screener
See Sudarshan Pharma Industries shareholding pattern with promoter, FII, and DII holdings.
Check Sudarshan Pharma Industries promoter holding and ownership changes for SUDARSHAN on TickJournal.
| Item | 2026-Aug | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 58.93% | 58.93% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% |
| FII Holding | 0.00% | 19.38% | 19.95% | 19.78% | 20.79% | 19.48% | 18.45% | 13.07% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.00% | 0.00% |
| Public Holding | 17.27% | 16.37% | 16.41% | 16.88% | 16.30% | 17.14% | 18.18% | 23.20% |
| Other Holding | 23.75% | 5.27% | 6.20% | 5.90% | 5.46% | 5.94% | 5.98% | 6.33% |
| Shareholder Count | 1,217 | 1,231 | 1,346 | 1,407 | 1,383 | 1,327 | 1,212 | 787 |
Sudarshan Pharma Industries Share Dividend Screener - Share Yield Analysis
Check Sudarshan Pharma Industries dividend history with payout and yield data.
View Sudarshan Pharma Industries dividend details including ex-dates and amounts for SUDARSHAN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.30 | 4.05% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sudarshan Pharma Industries Stock Index Membership
See which indices include Sudarshan Pharma Industries stock.
Check SUDARSHAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sudarshan Pharma Industries Market Events Screener - Corporate Actions
Get Sudarshan Pharma Industries corporate actions including splits, bonuses, and buybacks.
Check Sudarshan Pharma Industries stock events that may affect SUDARSHAN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-22 | 2026-09-22 | Annual General Meeting | NA | -1.05% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -0.26% |
| 2026-04-30 | 2026-04-30 | Quarterly Result Announcement | NA | -0.96% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -0.93% |
| 2025-10-18 | 2025-10-18 | Quarterly Result Announcement | NA | -2.36% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-11 | 2025-08-11 | Extraordinary General Meeting | NA | 2.74% |
| 2025-07-25 | 2025-07-25 | Annual General Meeting | NA | -8.80% |
| 2025-06-12 | 2025-06-12 | Extraordinary General Meeting | NA | 4.14% |
| 2025-04-24 | 2025-04-24 | Quarterly Result Announcement | NA | -5.82% |
| 2025-02-04 | 2025-02-04 | Extraordinary General Meeting | NA | -19.06% |
| 2024-11-23 | 2024-11-23 | Split | 1:10 | 4.99% |
| 2024-10-31 | 2024-10-31 | Quarterly Result Announcement | NA | 9.01% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -0.07% |
| 2024-09-30 | 2024-09-30 | Extraordinary General Meeting | NA | 94.52% |
Sudarshan Pharma Industries Competitors Screener - Peer Comparison
Screen SUDARSHAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sudarshan Chemical Industries | 9,303 | 111.58 | 9,866 | 191.99% | 41 | 48.72 |
| Kiri Industries | 3,407 | 0.60 | 840 | -1.78% | 5,444 | 54.55 |
| Bodal Chemicals | 2,225 | 31.56 | 2,054 | 16.92% | 48 | 81.18 |
| Indokem | 1,706 | 763.75 | 172 | -3.58% | 2 | 88.53 |
| Shree Pushkar Chemicals | 1,622 | 21.74 | 977 | 19.52% | 74 | 66.85 |
| Bhageria Industries | 1,338 | 20.40 | 881 | 46.41% | 45 | 66.91 |
| Ultramarine & Pigments | 1,215 | 13.57 | 786 | 11.21% | 81 | 49.44 |
| Sudarshan Pharma Industries | 974 | 39.45 | 703 | 38.51% | 23 | 50.42 |
| Sudarshan Colorants | 866 | 18.44 | 808 | -4.30% | 45 | 41.52 |
| Vipul Organics | 501 | 62.83 | 175 | 7.54% | 7 | 50.60 |
Sudarshan Pharma Industries Company Announcements - News Screener
Screen SUDARSHAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Updates on Acquisition | - | |
| 2026-09-15 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-09-15 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-09-11 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-29 | Reg. 34 (1) Annual Report. | - |
| 2026-08-29 | Reg. 34 (1) Annual Report. | - |
| 2026-08-29 | Annual General Meeting Of The Company On Tuesday 22/September/2026 | - |
| 2026-08-26 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-22 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-17 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-14 | FCCB Committee Meeting On Wednesday 19-August-2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Diversification / Disinvestment | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-08-12 | Financial Results For The Quarter Ended 30/06/2026 | - |